12.16.20 -- FDA's Office Of Minority Health And Health Equity Addresses Patient Diversity
12.16.20 -- FDA's Office Of Minority Health And Health Equity Addresses Patient Diversity AVROBIO president and CEO Geoff MacKay tells Business of Biotech about the technology his company is using to drive at-scale gene therapy production for lysosomal disorders and how they overcame a major manufacturing investment that didn't quite work as planned. Listen now and subscribe so you never miss an episode. Featured Editorial By Ed Miseta, chief editor, Clinical Leader The diversity of patients participating in clinical trials continues to be a problem in dr...
Source: clinicalleader.com